Cytosorbents CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
CytoSorbents Corporation has scheduled its 2026 Annual Meeting for August 13, 2026, to vote on director elections, executive compensation, and a proposed reverse stock split.
NASDAQ
Cytosorbents Corporation has filed a definitive proxy statement with the SEC.
NASDAQ
CytoSorbents Corporation will hold its annual meeting of stockholders virtually on June 12, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
CytoSorbents Corporation announces its 2024 Annual Meeting to be held virtually on June 6, 2024, with stockholders voting on director elections, executive compensation, an incentive plan amendment, and auditor ratification.
NASDAQ
CytoSorbents Corporation will hold its annual meeting of stockholders virtually on June 6, 2024, to vote on director elections, executive compensation, an amendment to the long-term incentive plan, and ratification of the independent accounting firm.